参考文献/References:
[1] 袁蕙芸,蒋宇飞,谭玉婷,等.全球癌症发病与死亡流行现状和变化趋势[J].肿瘤防治研究,2021,48(6):642-646.
[2] 岳 英,董锦华,肖月梅.肺免疫微环境中调节因子表达对肿瘤生长和转移的影响[J].陕西医学杂志,2021,50(4):495-498,502.
[3] 栾英桥,杨佳幸,陶嫦立,等.肠道菌群影响肠道细胞免疫的研究进展[J].中国免疫学杂志,2018,25(34):1734-1737.
[4] 刘 峰,严 晶,卢冬雪,等.肠道微生态研究与中医本质探索[J].中医学报,2019,9(34):1859-1863.
[5] 吴国琳,余国友,卢雯雯,等.肠道微生态的中医本质探讨[J].中华中医药学刊,2015,33(11):2586-2588.
[6] 李玲霞,白 玲,张云清,等.分娩方式对学龄期儿童肺功能的影响[J].陕西医学杂志,2020,49(10):1277-1279.
[7] Thiele OE,Fan H,Tam AJ,et al.The myeloid immune signature of enterotoxigenic bacteroides fragilis-induced murine colon tumorigenesis[J].Mucosal Immunol,2017,10(2):421-433.
[8] Chen J,Pitmon E,Wang K.Microbiome,inflammation and colorectal cancer[J].Semin Immunol,2017,32:43-53.
[9] Cheng WY,Wu CY,Yu J.The role of gut microbiota in cancer treatment:Friend or foe?[J].Gut,2020,69(10):1867-1876.
[10] 张雪莹,秦环龙.肿瘤免疫治疗与肠道菌群关系的研究进展[J].上海预防医学,2019,31(10):817-823.
[11] Sivan A,Corrales L,Hubert N,et al.Commensal bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy[J].Science,2015,350(6264):1084-1089.
[12] Katayama Y,Yamada T,Shimamoto T,et al.The role of the gut microbiome on the efficacy of immune checkpoint inhibitors in japanese responder patients with advanced non-small cell lung cancer[J].Transl Lung Cancer Res,2019,8(6):847-853.
[13] Zheng Y,Wang T,Tu X,et al.Gut microbiome affects the response to anti-PD-1 immunotherapy in patients with hepatocellular carcinoma[J].J Immunother Cancer,2019,7(1):193.
[14] Gopalakrishnan V,Spencer CN,Nezi L,et al.Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients[J].Science,2018,359(6371):97-103.
[15] 张晓博,杨宪武,党惠娇,等.IL-8和TNF-α在美沙拉嗪和美常安胶囊在治疗溃疡性结肠炎患者血清中表达变化[J].河北医药,2010,32(5):589-590.
[16] Xia C,Jiang C,Li W,et al.A phase Ⅱ randomized clinical trial and mechanistic studies using improved probiotics to prevent oral mucositis induced by concurrent radiotherapy and chemotherapy in nasopharyngeal carcinoma[J].Front Immunol,2021,12:618150.
[17] 张阿润,刘传波,赵鹏飞,等.肠道菌群与肺癌关系的研究进展[J].癌症进展,2021,19(19):1950-1953.
[18] 李丽秋,张德慧,马淑霞,等.中草药白花蛇舌草对实验性大肠癌作用机制的研究[J].中国微生态学杂志,2008,20(3):224-225.
[19] 丁佳敏,张 竞,肖明明,等.方剂“从肠道菌群论治”的理论与实践[J].世界科学技术-中医药现代化,2018,20(2):157-161.
[20] 丁维俊,高 峰,杨 杰.肾阳虚证患者肠道菌群失调状况的临床研究[J].新中医,2007,39(1):9-11.
[21] 张 玉,张军峰,杨亚平.近十五年来肠道微生态的中医药研究概况[J].辽宁中医杂志,2016,43(11):2442-2445.
[22] 董开忠,高永盛,秦宁恩加,等.参苓白术散对抗生素引起肠道菌群失调小鼠的影响[J].中国实验方剂学杂志,2015,21(1):154-157.
[23] 袁文婷,肖茂良,肖 锋.半枝莲提取物通过PI3K-Akt信号通路抑制胰腺癌模型大鼠肿瘤生长的机制研究[J].陕西中医,2021,42(12):1676-1679.
[24] 敬秀平,宋小平,刘 珊.加味白头翁汤灌肠治疗慢性溃疡性结肠炎临床研究[J].陕西中医,2021,42(8):1060-1063.